Keros Therapeutics Inc. (KROS)

AI Score

Unlock

14.41

0.11 (0.77%)

At close: Apr 24, 2025, 12:29 PM

Dividends

No dividend history available for Keros Therapeutics Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Full Definition

Related Stocks

Company	Dividend Yield

Dividend Rankings

KROS News

1 week ago · KROS Initiates Exploring Strategic Alternatives, Stock Gains 18.5% - zacks.com
2 weeks ago · Keros Therapeutics Goes Up For Sale On Heels Of Stockholder Rights Plan - benzinga.com
2 weeks ago · Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump - benzinga.com
1 week ago · Keros Therapeutics adopts 'poison pill' plan - reuters.com
1 month ago · Wall Street Analysts Think Keros Therapeutics (KROS) Could Surge 156.99%: Read This Before Placing a Bet - zacks.com
1 month ago · Wall Street Analysts Believe Keros Therapeutics (KROS) Could Rally 153.67%: Here's is How to Trade - zacks.com
1 month ago · Keros Therapeutics, Inc. (KROS) Reports Q4 Loss, Misses Revenue Estimates - zacks.com
2 months ago · INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Keros Therapeutics, Inc. - KROS - accessnewswire.com
2 months ago · Kairos Pharma Oral Presentation on Its Investigational Compound KROS 101 at the 13th AACR-JCA Joint Conference Supports the Compound's Potential as a Therapeutic for Melanoma and Glioblastoma - businesswire.com
2 months ago · SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Keros Therapeutics, Inc. - KROS - accessnewswire.com